Chiome Bioscience Inc.
2 clinical trials · Sponsor
◉ Watch Chiome Bioscience Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. (NCT07016997) | Chiome Bioscience Inc. | 2022-06-27 |
| A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer (NCT06636435) | Chiome Bioscience Inc. | 2020-06-01 |
Track Chiome Bioscience Inc. automatically
Every clearance here is in the API, with alerts when new ones post.